PROFILE: Getting to know GSK dermatologist David Rubenstein, head to toe
This article was originally published in Scrip
Executive Summary
Dr David Rubenstein, a dermatologist and the current vice-president of discovery and preclinical development at GlaxoSmithKline's skin health treatment and research company, Stiefel, believes pharma has only gotten skin deep when it comes to dermatology drug development.